Effect of cholesterol-lowering agents on soluble epidermal growth factor receptor level in type 2 diabetes and hypercholesterolemia

Soluble epidermal growth factor receptor (sEGFR) levels are elevated in patients with type 2 diabetes mellitus (T2DM) and positively correlate with blood glucose and cholesterol levels. However, how cholesterol-lowering treatment in patients with T2DM affects the sEGFR level is unknown. Therefore, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jun Choul, Joung, Kyong Hye, Kim, Ji Min, Kang, Seon Mee, Kim, Hyun Jin, Ku, Bon Jeong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410686/
https://www.ncbi.nlm.nih.gov/pubmed/36042588
http://dx.doi.org/10.1097/MD.0000000000030287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410686/
https://www.ncbi.nlm.nih.gov/pubmed/36042588
http://dx.doi.org/10.1097/MD.0000000000030287

Ejemplares similares